Vision Incubate
VC Fund
Kanazawa, Japan
Vision Incubate is a VC fund in Kanazawa focused on Medical and Therapeutics. Vision Incubate operates as an investment firm.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Vision Incubate invests in
Stages Vision Incubate invests in
Countries Vision Incubate invests in
Investment Focus
Industry
- Medical 2 (33%)
- Therapeutics 2 (33%)
- Biotechnology 2 (33%)
- Artificial Intelligence 2 (33%)
- B2B 1 (17%)
Stage
- Series A 2 (33%)
- Seed 1 (17%)
- Pre-Seed 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
Country
- Japan 5 (83%)
- United States 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CORE Biomedicine
|
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology. | $21M / Series A / Jul 28, 2026 | |
Anaut
|
Anaut specializes in software development utilizing artificial intelligence for surgical support in surgical medicine. | Series B / Mar 01, 2026 | |
FerroptoCure
|
FerroptoCure is a research firm that specializes in ferroptosis research and the development of therapeutic drugs to treat diseases. | $3.1M / Series A / Sep 19, 2025 | |
MoveEz
|
MoveEz develops mapless autonomous driving technology using proprietary perception and decision-making systems. Their solutions enable sustainable, all-weather autonomous mobility without relying on high-precision digital maps. | Pre-Seed / Apr 01, 2025 | |
THE PHAGE
|
The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels. | Seed / Sep 12, 2024 | |
Optieum Biotechnologies
|
Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need. |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Vision Incubate invest in?
Vision Incubate invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Vision Incubate last invest?
The most recent investment recorded for Vision Incubate closed in Jul 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
